255 related articles for article (PubMed ID: 21997683)
1. Ossifying fibromyxoid tumor of soft parts: a clinicopathologic, proteomic, and genomic study.
Graham RP; Dry S; Li X; Binder S; Bahrami A; Raimondi SC; Dogan A; Chakraborty S; Souchek JJ; Folpe AL
Am J Surg Pathol; 2011 Nov; 35(11):1615-25. PubMed ID: 21997683
[TBL] [Abstract][Full Text] [Related]
2. Ossifying fibromyxoid tumor: a study of 6 cases of atypical and malignant variants.
Dantey K; Schoedel K; Yergiyev O; McGough R; Palekar A; Rao UNM
Hum Pathol; 2017 Feb; 60():174-179. PubMed ID: 27816723
[TBL] [Abstract][Full Text] [Related]
3. Ossifying fibromyxoid tumor of soft parts: a clinicopathologic study of 70 cases with emphasis on atypical and malignant variants.
Folpe AL; Weiss SW
Am J Surg Pathol; 2003 Apr; 27(4):421-31. PubMed ID: 12657926
[TBL] [Abstract][Full Text] [Related]
4. PHF1 rearrangements in ossifying fibromyxoid tumors of soft parts: A fluorescence in situ hybridization study of 41 cases with emphasis on the malignant variant.
Graham RP; Weiss SW; Sukov WR; Goldblum JR; Billings SD; Dotlic S; Folpe AL
Am J Surg Pathol; 2013 Nov; 37(11):1751-5. PubMed ID: 23887158
[TBL] [Abstract][Full Text] [Related]
5. Novel recurrent PHF1-TFE3 fusions in ossifying fibromyxoid tumors.
Suurmeijer AJH; Song W; Sung YS; Zhang L; Swanson D; Fletcher CDM; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2019 Sep; 58(9):643-649. PubMed ID: 30920708
[TBL] [Abstract][Full Text] [Related]
6. Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1.
Kao YC; Sung YS; Zhang L; Chen CL; Huang SC; Antonescu CR
Genes Chromosomes Cancer; 2017 Jan; 56(1):42-50. PubMed ID: 27537276
[TBL] [Abstract][Full Text] [Related]
7. Ossifying fibromyxoid tumor: a clinicopathologic analysis of 26 subcutaneous tumors with emphasis on differential diagnosis and prognostic factors.
Atanaskova Mesinkovska N; Buehler D; McClain CM; Rubin BP; Goldblum JR; Billings SD
J Cutan Pathol; 2015 Sep; 42(9):622-31. PubMed ID: 25950586
[TBL] [Abstract][Full Text] [Related]
8. Ossifying fibromyxoid tumor: modified myoepithelial cell tumor? Report of three cases with immunohistochemical and electron microscopic studies.
Min KW; Seo IS; Pitha J
Ultrastruct Pathol; 2005; 29(6):535-48. PubMed ID: 16316954
[TBL] [Abstract][Full Text] [Related]
9. Atypical ossifying fibromyxoid tumor unusually located in the mediastinum: report of a case showing mosaic loss of INI-1 expression.
Tajima S; Koda K
Int J Clin Exp Pathol; 2015; 8(2):2139-45. PubMed ID: 25973116
[TBL] [Abstract][Full Text] [Related]
10. Ossifying Fibromyxoid Tumor: An Update.
Bakiratharajan D; Rekhi B
Arch Pathol Lab Med; 2016 Apr; 140(4):371-5. PubMed ID: 27028395
[TBL] [Abstract][Full Text] [Related]
11. Primary malignant ossifying fibromyxoid tumour of the bone. A clinicopathologic and molecular report of two cases.
Sbaraglia M; Bellan E; Gambarotti M; Righi A; Zanatta L; Toffolatti L; Dei Tos AP
Pathologica; 2020 Dec; 112(4):184-190. PubMed ID: 33179613
[TBL] [Abstract][Full Text] [Related]
12. Expanding the molecular signatures of malignant ossifying fibromyxoid tumours with two novel gene fusions: PHF1::FOXR1 and PHF1::FOXR2.
Srivastava P; Zilla ML; Naous R; Marker D; Khoshnoodi P; Burgess M; Herradura A; Wu J; Surrey LF; John I
Histopathology; 2023 May; 82(6):946-952. PubMed ID: 36648026
[TBL] [Abstract][Full Text] [Related]
13. Ossifying fibromyxoid tumor: invariable ultrastructural features and diverse immunophenotypic expression.
Hirose T; Shimada S; Tani T; Hasegawa T
Ultrastruct Pathol; 2007; 31(3):233-9. PubMed ID: 17614002
[TBL] [Abstract][Full Text] [Related]
14. Ossifying Fibromyxoid tumor of soft parts in head and neck: case report and literature review.
Velasco IA; Zhang R; Li T; Wang D
Diagn Pathol; 2018 Mar; 13(1):21. PubMed ID: 29587781
[TBL] [Abstract][Full Text] [Related]
15. Atypical and malignant variants of ossifying fibromyxoid tumor. Clinicopathologic analysis of six cases.
Kilpatrick SE; Ward WG; Mozes M; Miettinen M; Fukunaga M; Fletcher CD
Am J Surg Pathol; 1995 Sep; 19(9):1039-46. PubMed ID: 7661277
[TBL] [Abstract][Full Text] [Related]
16. A PHF1-TFE3 fusion atypical ossifying fibromyxoid tumor with prominent collagenous rosettes: Case report with a brief review.
Zou C; Ru GQ; Zhao M
Exp Mol Pathol; 2021 Dec; 123():104686. PubMed ID: 34560087
[TBL] [Abstract][Full Text] [Related]
17. Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors.
Gebre-Medhin S; Nord KH; Möller E; Mandahl N; Magnusson L; Nilsson J; Jo VY; Vult von Steyern F; Brosjö O; Larsson O; Domanski HA; Sciot R; Debiec-Rychter M; Fletcher CD; Mertens F
Am J Pathol; 2012 Sep; 181(3):1069-77. PubMed ID: 22796436
[TBL] [Abstract][Full Text] [Related]
18. Novel MEAF6-SUZ12 fusion in ossifying fibromyxoid tumor with unusual features.
Killian K; Leckey BD; Naous R; McGough RL; Surrey LF; John I
Genes Chromosomes Cancer; 2021 Sep; 60(9):631-634. PubMed ID: 33840146
[TBL] [Abstract][Full Text] [Related]
19. PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells.
Hofvander J; Jo VY; Fletcher CDM; Puls F; Flucke U; Nilsson J; Magnusson L; Mertens F
Mod Pathol; 2020 Jul; 33(7):1331-1340. PubMed ID: 31932680
[TBL] [Abstract][Full Text] [Related]
20. Pediatric low-grade fibromyxoid sarcoma mimicking ossifying fibromyxoid tumor: adding to the diagnostic spectrum of soft tissue tumors with a bony shell.
Thway K; Chisholm J; Hayes A; Swansbury J; Fisher C
Hum Pathol; 2015 Mar; 46(3):461-6. PubMed ID: 25532939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
